These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33150391)

  • 41. Study of gammopathies with immunofixation electrophoresis.
    Sun T; Lien YY; Degnan T
    Am J Clin Pathol; 1979 Jul; 72(1):5-11. PubMed ID: 110139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defect in Automated Antigen Excess Detection Discovered after Reviewing Serum Free Light Chain Results in Context with Clinical Findings.
    Lao KM; Pokharel A; Elzieny MMMI; Sykes E; Truscott SM
    Lab Med; 2024 Jan; 55(1):106-108. PubMed ID: 37285521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Free light chains assay: Indications and methods].
    Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
    Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance.
    Rozenova K; Willrich M; Snyder M; Dasari S; Kourelis T; Rajkumar SV; Kumar S; Dispenzieri A; Murray DL
    J Appl Lab Med; 2023 Jul; 8(4):742-750. PubMed ID: 37232112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
    Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
    Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isoelectric focusing followed by affinity immunoblotting to detect monoclonal free light chains in monoclonal gammopathies: Comparison with immunofixation electrophoresis and free light chain ratio.
    Zeman D; Štork M; Švancarová L; Borský M; Pospíšilová M; Adam Z; Beňovská M; Pour L
    Ann Clin Biochem; 2024 Jul; 61(4):291-302. PubMed ID: 38073192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias.
    Levinson SS
    Clin Chem; 1991 Jun; 37(6):1122-6. PubMed ID: 1904799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
    Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urine Immunofixation Electrophoresis for Diagnosis of Monoclonal Gammopathy: Evaluation of Methods for Urine Concentration.
    Ye Mon M; Ufondu O; Mortley S; Bollag RJ; Singh G
    J Appl Lab Med; 2024 Mar; 9(2):350-356. PubMed ID: 38180079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differences identified between serum and urine immunofixation electrophoresis.
    Tracy E; Andrews DM; Constantin MA; Zhu Y
    Clin Chim Acta; 2015 Jan; 439():68-70. PubMed ID: 25307209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laboratory characterizations on 2007 cases of monoclonal gammopathies in East China.
    Wang H; Gao C; Xu L; Yang Z; Zhao W; Kong X
    Cell Mol Immunol; 2008 Aug; 5(4):293-8. PubMed ID: 18761817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of clinical guidelines, laboratory recommendations and external quality assurance programs for monoclonal gammopathy testing.
    Lim SM; Wijeratne N; Choy KW; Nguyen TTH; Setiawan L; Loh TP
    Crit Rev Clin Lab Sci; 2024 Mar; 61(2):107-126. PubMed ID: 37776896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies.
    Cárdenas MC; García-Sanz R; Puig N; Pérez-Surribas D; Flores-Montero J; Ortiz-Espejo M; de la Rubia J; Cruz-Iglesias E
    Clin Chem Lab Med; 2023 Nov; 61(12):2115-2130. PubMed ID: 37477188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of capillary zone and immunosubtraction with agarose gel and immunofixation electrophoresis for detecting and identifying monoclonal gammopathies.
    Litwin CM; Anderson SK; Philipps G; Martins TB; Jaskowski TD; Hill HR
    Am J Clin Pathol; 1999 Sep; 112(3):411-7. PubMed ID: 10478148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current role of the laboratory in the demonstration and follow up of monoclonal immunoglobulinopathy].
    Myara I
    Pathol Biol (Paris); 1990 Feb; 38(2):134-43. PubMed ID: 2107510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined light chain immunofixation to detect monoclonal gammopathy: a comparison to standard electrophoresis in serum and urine.
    Jenner W; Klingberg S; Tate JR; Wilgen U; Ungerer JP; Pretorius CJ
    Clin Chem Lab Med; 2014 Jul; 52(7):981-7. PubMed ID: 24566368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urine immunofixation electrophoresis remains important and is complementary to serum free light chain.
    Levinson SS
    Clin Chem Lab Med; 2011 Nov; 49(11):1801-4. PubMed ID: 21663562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IgD-λ multiple myeloma with excessive excretion of free light chains: a diagnostic trap in the identification of monoclonal gammopathies.
    Zahir H; Tali A; Rachidi M; Mouhib H; Daif H; Ait Ouzdi Z; Haouach K; Chabaa L
    Ann Biol Clin (Paris); 2019 Feb; 77(1):107-111. PubMed ID: 30799291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.
    Bradwell AR; Harding SJ; Fourrier NJ; Wallis GL; Drayson MT; Carr-Smith HD; Mead GP
    Clin Chem; 2009 Sep; 55(9):1646-55. PubMed ID: 19617289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.